Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4215194 Title: HÉRAPIE COMBINÉE D'UN BLOQUEUR DU RÉCEPTEUR AT1 ET D'UN INHIBITEUR DE CCR2 POUR LE TRAITEMENT, L'AMÉLIORATION OU LA PRÉVENTION D'UNE MALADIE RÉNALE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
231615501
WO application number:
Type:
European patent granted for BE
Status:
Open
Publication number:
4215194
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
11/01/2012
Grant date:
25/03/2026
EP publication date:
26/07/2023
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
25/03/2026
EP B1 publication date:
25/03/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
11/01/2032

Applicant

Name:
Dimerix Bioscience Pty Ltd
Legal Form:
From:
25/03/2026
Address:
WB Block Queen Elizabeth II Medical Centre Hospital Avenue, Nedlands, Western Australia 6009, Australia (AU)
To:

Inventor

1

Name:
PFLEGER, Kevin Donald George
Legal Form:
Address:
Nedlands, Western Australia, 6009, Australia (AU)

2

Name:
MCCALL, Elizabeth
Legal Form:
Address:
Dalkeith, Western Australia, 6009, Australia (AU)

3

Name:
WILLIAMS, James
Legal Form:
Address:
Como, Western Australia, 6152, Australia (AU)

Priority

1

Priority patent number:
2011904279
Priority date:
17/10/2011
Priority country:
Australia (AU)

2

Priority patent number:
2011900060
Priority date:
11/01/2011
Priority country:
Australia (AU)

3

Priority patent number:
201161547951 P
Priority date:
17/10/2011
Priority country:
United States (US)

4

Priority patent number:
201161432896 P
Priority date:
14/01/2011
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/41; A61K 31/80; A61P 9/06; A61K 31/537; A61P 9/00; A61P 9/12; A61P 13/12;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2026/06
Publication date:
10/04/2026
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202613
Publication date:
25/03/2026
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/02/2027
Annual fee number:
16
Annual fee amount:
400 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type